Clearwater advises Nordic Capital and Ober Scharrer Gruppe on the acquisition of Eyescan
Clearwater has advised Nordic Capital, a leading private equity investor in the Nordic region, and Ober Scharrer Gruppe (Ober Scharrer), a German eye care provider, on the acquisition of the leading Dutch eye care provider, Eyescan.
Nordic Capital aims to create stronger, sustainable businesses, through operational improvement, and transformative growth. Their core sectors are healthcare, technology and payments, financial services, industrial goods and services, and consumer and retail. Their key regions are the Nordics and Northern Europe, with a global focus on healthcare. Since its inception in 1989, Nordic Capital has invested €12bn in approximately 100 investments.
Founded in 1982, Ober Scharrer provides ophthalmic treatments and medical care across Germany. With almost 1,600 employees, the company operates in over 25 locations and treats more than 800,000 patients per year. In March 2018, Nordic Capital became the majority shareholder in Ober Scharrer.
Eyescan, established in 1999, is a leading Dutch eyecare clinic chain, providing eyecare surgery services and eye diseases treatments, whilst also providing cosmetic eye services. The company operates seven clinics in the Netherlands, including several joint ventures with hospitals.
The acquisition of Eyescan is the first cross-border transaction for Ober Scharrer.
